| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.6M | +24.2% |
| Cost of Revenue | $19.6M | +19.8% |
| R&D Expense | $29.3M | -1.3% |
| SG&A Expense | $11.7M | -8.0% |
| Operating Income | -$13.0M | +36.4% |
| Pre-tax Income | -$14.4M | +47.8% |
| Income Tax | $530K | — |
| Net Income | -$14.9M | +45.9% |
| EPS (Basic) | -$0.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | -56.1% |
| Accounts Receivable | $4.6M | +33.2% |
| Inventory | $16.8M | -6.4% |
| Current Assets | $44.9M | -27.2% |
| Total Assets | $55.8M | -24.3% |
| Current Liabilities | $32.4M | -2.3% |
| Total Liabilities | $66.4M | -16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.0M | -143.1% |
| Capital Expenditures | $628K | -57.0% |
| Investing Cash Flow | -$5.0M | -126.6% |
| Financing Cash Flow | $8.2M | -31.8% |
| Free Cash Flow | -$25.6M | -118.2% |
| +50.0% |
| EPS (Diluted) | -$0.31 | +50.0% |
| Stockholders' Equity |
| -$10.6M |
| -76.3% |